Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06085547 · ClinicalTrials.gov registry record · NA
Rural Tailored COVID-19 Communication to Promote SARS-CoV-2 Antibody Testing in Saliva
A NA study, sponsored by Michigan State University.
- Completed
- Registry status
- NA
- Development phase
- 264
- Enrollment target
NCT06085547 is a NA study that has completed, run by Michigan State University. The registered enrollment target is 264 participants.
The verdict
NCT06085547, a NA study, has completed, sponsored by Michigan State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 264 participants
- Enrollment target
Study Summary
This study seeks to evaluate communication strategies for better encouraging understanding and uptake of salivary SARS-CoV-2 antibody testing among individuals residing in rural Northern Michigan. This iteration will consider individuals recruited from rural Northern Michigan and assess individuals' willingness to participate in home-based saliva sample collections.
Interventions
- BEHAVIORAL General SARS-CoV-2 Communication
- BEHAVIORAL Rural-Targeted SARS-CoV-2 Communication
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 264 participants |
| Start Date | 2023-05-04 |
| Est. Completion | 2023-11-14 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06085547
The ClinicalTrials.gov registry entry for NCT06085547 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 264 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Michigan State University, which has 120 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which General SARS-CoV-2 Communication is the first listed.
NCT06085547 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06085547 about?
NCT06085547 is a clinical study titled "Rural Tailored COVID-19 Communication to Promote SARS-CoV-2 Antibody Testing in Saliva". This study seeks to evaluate communication strategies for better encouraging understanding and uptake of salivary SARS-CoV-2 antibody testing among individuals residing in rural Northern Michigan. This iteration will consider individuals recruited from rural Northern Michigan and assess individuals'...
What is the current status of trial NCT06085547?
This trial is currently completed. It is a NA study. The enrollment target is 264 participants. The study started on 2023-05-04. Estimated completion is 2023-11-14.
What interventions are being tested in trial NCT06085547?
The interventions under investigation include: General SARS-CoV-2 Communication (BEHAVIORAL), Rural-Targeted SARS-CoV-2 Communication (BEHAVIORAL).
Who is sponsoring clinical trial NCT06085547?
This trial is sponsored by Michigan State University, which has 120 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.